Nerve growth factor induces the re-expression of functional androgen receptors and p75NGFR in the androgen-insensitive prostate cancer cell line DU145

European Journal of Endocrinology

Volumn 147, Issue 3, 2002, Pages 407-415

  Sigala, Sandra ^a   Tognazzi, Nadia ^a   Rizzetti, Maria Cristina ^a   Faraoni, Isabella ^a   Missale, Cristina ^a   Bonmassar, Enzo ^a   Spano, PierFranco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; CYPROTERONE ACETATE; HYDROXYFLUTAMIDE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN; PROTEIN P75; RNA DIRECTED DNA POLYMERASE; SEX HORMONE ANTAGONIST; TELOMERASE;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CARCINOGENICITY; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HORMONE RESISTANCE; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; REVERTANT;

EID: 0036740678     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470407     Document Type: Article

References (34)

1. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ et al. The endocrinology and developmental biology of the prostate. Endocrine Review 1987 8 338-362.
2. Wahli W & Martinez E. Superfamily of steroid nuclear receptors - positive and negative regulator of gene expression. FASEB Journal 1991 5 2243-2249.
3. Isaacs JT, Schulze H & Coffey DS. Development of androgen resistance in prostatic cancer. Progress in Clinical and Biological Research 1987 243 21-31.
4. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Zhang J et al. Regulation of prostatic growth and function by peptide growth factors. Prostate 1996 28 392-405.
5. Yano H & Chao MV. Neurotrophin receptor structure and interactions. Pharmaceutica Acta Helvetiae 2000 74 253-260.
6. Harper GP & Thoenen H. Guinea pig prostate is a rich source of nerve growth factor. Nature 1979 279 160-162.
7. Djakiew D, Delsite R, Pflug B, Wrathall J, Lynch JH & Onoda M. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate. Cancer Research 1991 51 3304-3310.
8. Graham CW, Lynch JH & Djakiew D. Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. Journal of Urology 1992 147 1444-1447.
9. MacGrogan D, Saint-Andrè J-P & Dicou E. Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. Journal of Neurochemistry 1992 59 1381-1391.
10. Paul AB, Grant ES & Habib FK. The expression and localization of β-nerve growth factor (β-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation. British Journal of Cancer 1996 74 1990-1996.
11. Pflug BR, Dionne C, Kaplan DR, Lynch J & Djakiew D. Expression of a Trk high affinity nerve growth factor receptor in the human prostate. Endocrinology 1995 136 262-268.
12. Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C, Bonmassar E et al. Suppression of telomerase, reexpression of KAI1 and abrogation of tumorigenicity in prostate cancer cell lines. Clinical Cancer Research 1999 5 1211-1218.
13. Yoon SO, Casaccia-Bonnefil P, Carter B & Chao MV. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. Journal of Neuroscience 1998 18 3273-3281.
14. NTR and apoptosis: Trk-dependent and Trk-independent effects. Trends in Neurosciences 1997 20 287-290.
15. Pflug BR, Onoda M, Lynch JH & Djakiew D. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Research 1992 52 5403-5406.
16. NTR in a human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death. Molecular Carcinogenesis 1998 23 106-114.
17. Kim N-W, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho WE et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994 266 2011-2015.
18. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW & Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Research 1996 56 218-222.
19. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M & Kubota Y. Telomerase activity in primary prostate cancer. Journal of Urology 1997 157 1161-1165.
20. Urquidi V, Tarin D & Goodison S. Role of telomerase in cell senescence and oncogenesis. Annual Review of Medicine 2000 51 65-79.
21. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genetics 1997 17 498-502.
22. Stone KR, Mickey DD, Wunderli H, Mickey GH & Paulson DF Isolation of a human prostate carcinoma cell line (DU145). International Journal of Cancer 1978 21 274-281.
23. Culig Z, Klocker H, Eberle J, Kaspar R Hobisch A, Cronauer MV et al. DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 1993 22 11-22.
24. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE et al. Detection of telomerase activity in human cells and tumor by telomeric repeat amplification protocol. Methods in Cell Sciences 1995 17 1-15.
25. Chomczynski P & Sacchi N. Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1989 162 156-163.
26. Stearn ME & McGarvey T. Biology of the disease. Prostate cancer: therapeutics, diagnostic and basic studies. Laboratory Investigation 1992 67 540-555.
27. Koivisto P, Kolmer M, Visakorpi T & Kallioniemi OP. Androgen receptor gene and hormonal therapy failure of prostate cancer. American Journal of Pathology 1998 152 1-9.
28. Nakayama T, Watanabe M, Suzuki H, Toyota M, Sekita N, Hirokawa Y et al. Epigenetic regulation of androgen receptor gene expression in human prostate cancers. Laboratory Investigation 2000 80 1789-1796.
29. Deng J & Szyf M. Downregulation of DNA (cytosine-5-)methyltransferase is a late event in NGF-induced PC12 cell differentiation. Molecular Brain Research 1999 71 23-31.
30. Izbicka E, McDonald J, Davidson K, Lawrence RA, Gomez L & Von Hoff D. 5,6-Dihydro-5′-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells. Anticancer Research 1999 19 1285-1292.
31. Suenaga M, Soda H, Oka M, Yamaguchi A, Nakatomi K, Shiozawa K et al. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. International Journal of Cancer 2002 97 621-625.
32. Chao MV & Hempstead BL. p75 and Trk: a two-receptor system. Trends in Neurosciences 1995 18 321-326.
33. NGFR and trkA. Journal of Neuroscience Research 1998 51 442-453.
34. NGFR affinity states is mediated by direct reciprocal interactions. European Journal of Neurosciences 1998 10 890-898.